In a groundbreaking study published in Nature Communications, researchers at Bar-Ilan University have unveiled a startling genetic discovery: altering a single nucleotide in a non-coding DNA sequence can entirely switch the sexual development trajectory of mice. This shift occurs not within a protein-coding gene, but rather in a regulatory element controlling one of the fundamental genes essential for testis formation. The study, led by Dr. Nitzan Gonen and doctoral researcher Elisheva Abberbock, sheds light on the profound influence of non-coding genomic regions—often overlooked “dark matter” of the genome—in orchestrating developmental fates.
The team’s focal point was a tiny regulatory DNA segment known as Enh13, which serves a pivotal role in modulating the expression of SOX9, a transcription factor critical for testis development. In a typical female (XX) mouse, SOX9 remains repressed, permitting ovarian development. Conversely, in males (XY), this gene becomes active, steering the embryonic gonad toward testis formation. Enh13 functions as a molecular battleground where protein factors promoting male or female pathways compete to regulate SOX9’s activity. Small perturbations in this regulatory landscape can thus have massive developmental consequences.
Employing the precision of CRISPR genome editing, the researchers introduced a one-base-pair insertion mutation within Enh13. Remarkably, this minimal genetic tweak was sufficient to disrupt the normally female-specific repression of SOX9 in XX mice. As a result, these genetically female individuals underwent complete sex reversal, developing testes and male external genitalia in place of ovaries. The data indicates that Enh13 must be carefully regulated: acting to activate SOX9 in males while ensuring its silencing in females.
Further experiments introduced a three-base-pair deletion in the same region, which also induced the sex reversal phenotype. These complementary mutations highlight how delicate and finely tuned the regulatory controls within Enh13 are, underscoring the complexity of non-coding DNA’s functional architecture. Cell-line reporter assays provided biochemical evidence showing how these mutations impair the binding of transcriptional repressors that normally prevent SOX9 expression in females.
The implications of this discovery reach well beyond basic developmental biology. Differences of Sex Development (DSD), a group of congenital conditions affecting approximately 1 in every 4,000 births worldwide, remain puzzling due to a lack of identifiable genetic causes in over half of the cases. Traditional genetic screenings focus primarily on protein-coding genes, largely neglecting non-coding regulatory regions. This study highlights the importance of exploring these vast, non-coding landscapes where subtle mutations can have outsized effects on gene expression and phenotype.
Notably, this investigation builds on previous research published earlier in 2024 by the same group, where mutations within Enh13 led to the converse outcome: XY mice developing with female characteristics due to the failure to activate SOX9. Together, the complementary studies illustrate Enh13’s bifunctional role as both enhancer and repressor depending on the sex chromosome context, revealing a fascinating molecular switch mechanism at the heart of mammalian sex determination.
Elisheva Abberbock, the doctoral student spearheading the project, emphasized that these findings challenge the prevailing gene-centric paradigm in genetic diagnostics and research. “It’s not enough to look only at the genes themselves,” she asserted. “Non-coding DNA sequences like enhancers harbor crucial regulatory elements that can be the root cause of developmental disorders and disease when mutated.”
In the broader context of genomics, this research opens a promising frontier for the systematic identification and functional characterization of regulatory sequences involved in sex determination and beyond. The team’s ongoing work aims to map additional enhancers and silencers that influence key developmental genes, with hopes of ultimately improving diagnostic and therapeutic strategies for DSD and related conditions.
The study’s innovative approach highlights the power of CRISPR-based editing combined with functional assays to deconvolute the complex gene regulatory networks encoded in non-coding DNA. It also reinforces the emerging understanding that the 98% of the human genome once dismissed as “junk” contains vital instructions that govern development, health, and disease.
Funded by the Israel Science Foundation and an ERC Starting Grant, the collaborative effort included contributions from Dr. Ariel Afek at the Weizmann Institute and Dr. Francis Poulat at the University of Montpellier. Their collective expertise underscores the interdisciplinary nature of modern genomic research, bridging molecular biology, genetics, and computational analysis to unravel the intricacies of development.
This landmark discovery not only enhances our biological knowledge of how sex is determined in mammals but also provides a compelling example of how minimal genetic alterations in regulatory DNA can produce dramatic phenotypic changes. It challenges scientists and clinicians alike to look beyond the protein-coding sequence, emphasizing a holistic genomic perspective that could revolutionize the understanding and treatment of developmental disorders.
Subject of Research: Sexual development, gene regulation, non-coding DNA, gene enhancers, sex reversal, CRISPR genome editing
Article Title: One DNA Letter Can Trigger Complete Sex Reversal, Bar-Ilan University Study Finds
News Publication Date: 9-Apr-2026
Web References:
https://www.nature.com/articles/s41467-026-71328-9
References:
Bar-Ilan University research article in Nature Communications, DOI: 10.1038/s41467-026-71328-9
Image Credits: Courtesy Bar-Ilan University
Keywords
Sex determination, non-coding genome, Enh13, SOX9, CRISPR, gene regulation, sex reversal, Differences of Sex Development (DSD), molecular biology, developmental genetics, transcriptional enhancers, genome editing
